Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Prelude Therapeutics, Inc.
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
June 03, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
May 09, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
April 09, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
March 05, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
February 29, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
February 15, 2024
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces $25 Million Private Placement
December 11, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
November 01, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
October 14, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
August 29, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
August 03, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics To Participate in Jefferies Healthcare Conference
May 31, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces Pricing of Public Offering
May 18, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces Launch of Proposed Public Offering
May 17, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
May 08, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
April 27, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
April 11, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
March 15, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene to Evaluate PRT2527 in Combination with Zanubrutinib in Hematologic Cancers
March 15, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics To Participate in Barclays Global Healthcare Conference
March 01, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
February 09, 2023
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Prelude Therapeutics Receives FDA Clearance of IND for PRT3789, a Potent and Selective First-in-Class SMARCA2 Protein Degrader
October 18, 2022
From
Prelude Therapeutics, Inc.
Via
GlobeNewswire
Tickers
PRLD
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit